NEOADJUVANT CHEMOTHERAPY (NAC) WITH DOCETAXEL AND LIPOSOME-ENCAPSULATED DOXORUBICIN IN LOCALLY ADVANCED HER2-BREAST CANCER (LABC)

被引：0
|
作者：
Merlano, M. C. [1 ]
Airoldi, M. [2 ]
Pedani, F. [2 ]
Contu, V. [2 ]
Margiotta, C. [2 ]
Fiore, J. [2 ]
机构：
[1] St Croce Gen Hosp, Dept Med Oncol, Cuneo, Italy
[2] San Giovanni Battista Hosp, Med Oncol Div 2, Turin, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Liposome-encapsulated doxorubicin plus paclitaxel and trastuzumab as neoadjuvant chemotherapy for operable and locally advanced breast cancer.
    Rossi, D.
    Pistilli, B.
    Morale, D.
    Baldelli, A.
    Casadei, V.
    Benedetti, G.
    Fedeli, S. Luzi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [3] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
  • [4] Gross and histologic features of locally advanced breast cancer (LABC) after neoadjuvant chemotherapy (NAC).
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 122 - 122
  • [5] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
  • [6] Neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-breast cancer
    Bear, Harry Douglas
    Idowu, Michael O.
    Poklepovic, Andrew
    Sima, Adam
    Kmieciak, Maciej
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [7] Liposome-encapsulated doxorubicin in metastatic breast cancer
    Boer R.D.
    [J]. Breast Cancer Research, 3 (1)
  • [8] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [9] Sequential doxorubicine (DOX) and docetaxel (DOC) as neoadjuvant chemotherapy in locally advanced breast cancer (LABC): A pilot study
    Wynendaele, W
    Paridaens, R
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S15 - S15
  • [10] Discordance between molecular markers (ER, HER2 and TOP2A) before and after neoadjuvant chemotherapy (NAC) in locally advanced breast cancer (LABC)
    Tuxen, M. K.
    Balslev, E.
    Cold, S.
    Tange, U. B.
    Carlsen, D.
    Nielsen, D. L.
    [J]. TUMOR BIOLOGY, 2012, 33 : 84 - 84
12345